News
6hon MSN
The most measured man on the planet is considering selling his anti-aging supplement company to focus on his new religion: ...
The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older ...
Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of ...
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...
1d
Nigerian Tribune on MSNNovel blood test predicts preeclampsia months before onsetA new blood test, a liquid biopsy of maternal plasma cell-free RNA (cfRNA) developed by iPremom, can predict pre-eclampsia up ...
The ZenoTOF 8600 system was used to measure the bile acid content of human plasma sample extracts using both CID- and ...
14h
GlobalData on MSNRoche’s Elecsys pTau181 test gains CE Mark to rule out Alzheimer’sA multi-centre, prospective trial involving 787 subjects across Australia, Europe, and the US formed the basis for the CE ...
Bryan Johnson aims to live beyond death. He is creating Bryan AI, a digital version of himself. This AI will learn from his ...
The National Medical Products Administration approved the marketing of a rice-derived recombinant human albumin injection on ...
I am visiting the Guérande salt marshes to meet Xavier Delamare, the UK’s sole importer of Sel de Guérande. He’s not just a ...
Bryan Johnson considers shutting down or selling Blueprint, his anti-ageing project, to focus on a new movement called ‘Don't ...
First Devices Customized for a Plasma-Derived Therapy in Takeda’s Broad and Differentiated Portfolio Reflect Company’s Commitment to Providing a Patient-Centric Ecosystem of Support Takeda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results